Chronic administration of a tyrosine kinase inhibitor restores functional and morphological changes of the basilar artery during chronic hypertension

Journal of Hypertension

Volumn 20, Issue 11, 2002, Pages 2205-2211

  Kitayama, Jiro ^a   Kitazono, Takanari ^a   Ooboshi, Hiroaki ^a   Ago, Tetsuro ^a   Ohgami, Tetsuya ^b   Fujishima, Masatoshi ^a   Ibayashi, Setsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Mitsubishi Welfarma Co Ltd   (Japan)

Author keywords

Endothelium; Smooth muscle; Tyrosine kinase; Vasodilation

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (N ACETYL N HYDROXYAMINO) 6 CYANO 3,4 DIHYDRO 2,2 DIMETHYL 2H 1 BENZOPYRAN 3 OL; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; GENISTEIN; POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RHO KINASE; VASCULOTROPIN; ANTIHYPERTENSIVE AGENT; BENZOPYRAN DERIVATIVE; ENZYME INHIBITOR; PROTEIN TYROSINE KINASE; VASODILATOR AGENT;

ANIMAL MODEL; ARTERY DIAMETER; ARTERY RESISTANCE; ARTICLE; BASILAR ARTERY; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BASILAR ARTERY; BENZOPYRANS; CHRONIC DISEASE; ENZYME INHIBITORS; GENISTEIN; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; PROTEIN-TYROSINE KINASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASODILATION; VASODILATOR AGENTS;

EID: 0036854547     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200211000-00020     Document Type: Article

References (42)

1. Mayhan WG, Faraci FM, Heistad DD. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol 1987; 253:H1435-H1440.
2. Yang ST, Mayhan WG, Faraci FM, Heistad DD. Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension 1991; 17:612-618.
3. Kitazono T, Ibayashi S, Nagao T, Fujii K, Kagiyama T, Fujishima M. Role of tyrosine kinase in dilator responses of rat basilar artery in vivo. Hypertension 1998; 31:861-865.
4. Kitayama J, Kitazono T, Ibayashi S, Wakisaka M, Watanabe Y, Kamouchi M, et al. Role of phosphatidylinositol 3-kinase in acetylcholine-induced dilator responses of rat basilar artery. Stroke 2000; 31:2487-2493.
5. Kitazono T, Faraci FM, Heistad DD. L-Arginine restores dilator responses of the basilar artery to acetylcholine during chronic hypertension. Hypertension 1996; 27:893-896.
6. Kitazono T, Faraci FM, Taguchi H, Heistad DD. Role of potassium channels in cerebral blood vessels. Stroke 1995; 26:1713-1723.
7. Kitazono T, Faraci FM, Heistad DD. ATP-sensitive potassium channels in the basilar artery during chronic hypertension. Hypertension 1993; 22:677-681.
8. Takaba H, Nagao T, Ibayashi S, Kitazono T, Fujii K, Fujishima M. Altered cerebrovascular response to a potassium channel opener in hypertensive rats. Hypertension 1996; 28:143-146.
9. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389:990-994.
10. Chrissobolis S, Sobey CG. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension; comparison with protein kinase C. Circ Res 2001; 88:774-779.
11. Kitazono T, Ago T, Kamouchi M, Santa N, Ooboshi H, Fujishima M, Ibayashi S. Increased activity of calcium channels and Rho-associated kinase in the basilar artery during chronic hypertension in vivo. J Hypertens 2002; 20:879-884.
12. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989; 13:968-972.
13. Intengen HD, Schiffrin EL. Vascular remodeling in hypertension; roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38:581-587.
14. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13:305-314.
15. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: Role of tyrosine kinases. Circ Res 1997; 80:607-616.
16. Berk BC. Vascular smooth muscle growth; autocrine growth mechanisms. Physiol Rev 2001; 81:999-1030.
17. Schieffer B, Paxton WG, Marrero MB, Bernstein KE. Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling. Hypertension 1996; 27:476-480.
18. Schieffer B, Paxton WG, Chai Q, Marrero MB, Bernstein KE. Angiotensin II controls p21 ras activity via pp6Oc-src. J Biol Chem 1996; 271:10329-10333.
19. Schieffer B, Drexler H, Ling BN, Marrero MB. G protein-coupled receptors control vascular smooth muscle cell proliferation via pp6Oc-src and p21ras. Am J Physiol 1997; 272:C2019-C2030.
20. Marrero MB, Schieffer B, Paxton WG, Duff JL, Berk BC, Bernstein KE. The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signaling. Cardiovasc Res 1995; 30:530-536.
21. Peifley KA, Winkles JA. Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells. Biochem Biophys Res Comm 1998; 242:202-208.
22. Florian J, Watts SW. Epidermal growth factor: A potent vasoconstrictor in experimental hypertension. Am J Physiol 1999; 45:H976-H983.
23. Natarajan R, Rosdahl J, Gonzales N, Bai W. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension 1997; 30:873-879.
24. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990; 16:532-540.
25. Levitzki A. Signal-transduction therapy; a novel approach to disease management. Eur J Biochem 1994; 226:1-13.
26. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 1987; 262:5592-5595.
27. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993; 265:H586-592.
28. Schelaeppi JM, Wood JM. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine kinase inhibitors. Cancer Metastasis Rev 1999; 18:473-481.
29. Faraci FM, Heistad DD, Mayhan WG. Role of large arteries in regulation of blood flow to brain stem in cats. J Physiol 1987; 387:115-123.
30. Kitazono T, Faraci FM, Heistad DD. Effect of norepinephrine on rat basilar artery in vivo. Am J Physiol 1993; 264:H178-H182.
31. Kitayama J, Kitazono T, Ooboshi H, Takada J, Fujishima M, Ibayashi S. Long-term effects of benidipine on cerebral vasoreactivity in hypertensive rats. Eur J Pharmacol 2002; 438:153-158.
32. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-g1 in vascular smooth muscle cells. J Biol Chem 1994; 269:10935-10939.
33. Schelling JR, Nkemere N, Konieczkowski M, Martin KA, Dubyak GR. Angiotensin II activates the b1 isoform of phospholipase C in vascular smooth muscle cells. Am J Physiol 1997; 272:C1558-C1566.
34. Pan J, Fukuda K, Kodama H, Makino S, Takahashi T, Sano M et al. Role of angiotensin II activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res 1997; 81:611-617.
35. McWhinney CD, Dostal D, Baker K. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. J Mol Cell Cardiol 1998; 30:751-761.
36. Wilkie N, Ng LL, Boarder MR. Angiotensin II responses of vascular smooth muscle cells from hypertensive rats: Enhancement at the level of p42 and p44 mitogen activated protein kinase. Br J Pharmacol 1997; 122:209-216.
37. Okuda M, Kawahara Y, Yokoyama M. Angiotensin II type 1 receptor-mediated activation of Ras in cultured rat vascular smooth muscle cells. Am J Physiol 1996; 271:H595-H601.
38. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989; 83:1419-1424.
39. Stouffer GA, Shimizu RT, Tubla MB, Owens GK. ANG II- or AVP-induced increases in protein synthesis are not dependent on autocrine secretion of PDGF-AA. Am J Physiol 1993; 264:C390-C395.
40. Ali S, Becker MW, Davis MG, Dorn II GW. Dissociation of vasoconstrictor-stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells: Relevant roles of protein kinase C. Circ Res 1994; 75:836-843.
41. Delafontaine P, Lou H. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem 1993; 268:16866-16870.
42. Heistad DD, Baumbach GL, Kitazono T, Faraci FM. Effects of hypertension on cerebral blood vessels. Hypertens Res 1993; 16:225-231.